Skip to main content
SpringerLink
Log in

Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”

  • Letter to the Editor
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

A Correction to this article was published on 02 December 2022

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

References

  1. Surjan J, Grossi JD, Del Porto JA, Delfino RS, de Oliveira CR, Lucchese AC, Magalhães E, Del Sant LC, Tuena MA, Nakahira C, Fava VAR, Steglich MS, Abdo GL, Barbosa MG, Sarin LM, Lacerda ALT. Efficacy and safety of subcutaneous esketamine in the treatment of suicidality in major depressive disorder and bipolar depression. Clin Drug Investig. 2022;42(9):653–64. https://doi.org/10.1007/s40261-022-01193-z.

    Article  CAS  Google Scholar 

  2. Fu DJ, Ionescu DF, Li X, Lane R, Lim P, Sanacora G, Hough D, Manji H, Drevets WC, Canuso CM. Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I). J Clin Psychiatry. 2020;81(3):19m13191. https://doi.org/10.4088/JCP.19m13191.

    Article  Google Scholar 

  3. Ionescu DF, Fu DJ, Qiu X, Lane R, Lim P, Kasper S, Hough D, Drevets WC, Manji H, Canuso CM. Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II). Int J Neuropsychopharmacol. 2021;24(1):22–31. https://doi.org/10.1093/ijnp/pyaa068.

    Article  Google Scholar 

  4. Wilkowska A, Wiglusz MS, Gałuszko-Wegielnik M, Włodarczyk A, Cubała WJ. Antianhedonic effect of repeated ketamine infusions in patients with treatment resistant depression. Front Psychiatry. 2021;12:704330. https://doi.org/10.3389/fpsyt.2021.704330.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, ul. Smoluchowskiego 17, 80-214, Gdańsk, Poland

    Alina Wilkowska & Wiesław Jerzy Cubała

Authors
  1. Alina Wilkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wiesław Jerzy Cubała
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alina Wilkowska.

Ethics declarations

Funding

No funding was received to write this letter.

Conflicts of interest

Dr Alina Wilkowska has received research support from Biogen, Janssen-Cilag, Lundbeck, Polpharma, Sanofi. Prof. Wiesław J. Cubała has received research support from Acadia, Alkermes, Angelini, Auspex Pharmaceuticals, Celon, Cortexyme, Ferrier, GW Pharmaceuticals, Janssen, Minerva, NIH, NeuroCog, Otsuka, Servier, Sanofi.

Consent to participate

Not applicable.

Consent to Publish

Not applicable.

Ethics approval

Not applicable.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Authors contributions

Both authors conceived and wrote the letter.

Additional information

The original online version of this article was revised: The author’s name Wiesław Jerzy Cubała was incorrectly written as Wiesław Jerzy Cuba.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wilkowska, A., Cubała, W.J. Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”. Clin Drug Investig 43, 79–80 (2023). https://doi.org/10.1007/s40261-022-01222-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-022-01222-x

Search

Navigation